Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
757 studies found for:    Erythropoietin
Show Display Options
Rank Status Study
1 Unknown  Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery
Conditions: Heart; Dysfunction Postoperative, Cardiac Surgery;   Anemia, Iron-Deficiency
Intervention: Drug: Erythropoietin subcutaneously and Iron intravenously
2 Completed Blood Sparing Strategies: Single Shot High Dose Erythropoietin Two Days Before Heart Surgery
Condition: Blood Transfusion
Intervention: Drug: Erythropoietin
3 Unknown  Intraocular Pharmacokinetics of Erythropoietin After Single Intravitreal Injection in Human
Conditions: Pharmacokinetics;   Erythropoietin
Intervention: Procedure: Vitrectomy
4 Unknown  Relationship Between Erythropoietin Administration and Stress Responses in Trauma Patients
Condition: Multiple Trauma
Interventions: Drug: erythropoietin;   Drug: placebo
5 Terminated
Has Results
An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy
Condition: Anemia - Cancer Related
Intervention: Drug: Erythropoietin: Observational study
6 Withdrawn Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia
Condition: Anemia
Intervention: Drug: Epoetin Alfa plus Iron
7 Completed Recombinant Human Erythropoietin Use in Intensive Care Unit (ICU) Patients: Does it Prevent Acute Renal Failure
Condition: Acute Renal Failure
Intervention: Drug: epoetinum
8 Completed HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD)
Condition: Chronic Kidney Disease
Intervention: Drug: HX575 epoetin alfa (Sandoz)
9 Completed Comparison Among Erythropoietin Stimulating Agents
Condition: Anemia of End Stage Renal Disease
Interventions: Drug: Epoetin alpha or beta (Epoetin group);   Drug: Darbepoetin alfa;   Drug: Methoxy polyethylene glycol-epoetin beta
10 Completed Neuroprotective Role of Erythropoietin in Perinatal Asphyxia
Condition: Perinatal Asphyxia
Intervention: Drug: Erythropoietin
11 Completed Erythropoietin and Platelet Activation Markers
Conditions: Thrombosis;   Hypertension
Intervention: Drug: erythropoietin
12 Active, not recruiting Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Conditions: Hypoxic-ischemic Encephalopathy;   Neonatal Encephalopathy;   Birth Asphyxia
Interventions: Drug: Erythropoietin;   Drug: Normal saline
13 Withdrawn Erythropoietin Alfa in Elderly Subjects With Unexplained Anemia
Condition: Anemia
Intervention: Drug: Epoetin alfa
14 Completed Erythropoietin Therapy for Subarachnoid Hemorrhage
Condition: Aneurysmal Subarachnoid Hemorrhage
Intervention: Drug: erythropoietin beta
15 Completed Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Conditions: Anemia;   Chronic Kidney Disease (CKD)
Interventions: Drug: HX575 epoetin alfa;   Drug: US-licensed epoetin alfa
16 Unknown  The Effects of Erythropoietin on Clinical Disability and Brain Pathology in Patients With Progressive Multiple Sclerosis
Condition: Multiple Sclerosis (Primary or Secondary Progressive Phase).
Intervention: Drug: Erythropoietin
17 Completed Erythropoietin in the Prevention of Acute Mountain Sickness
Condition: Acute Mountain Sickness
Intervention: Drug: Erythropoietin
18 Not yet recruiting High-dose Erythropoietin for Asphyxia and Encephalopathy
Conditions: Neonatal Encephalopathy;   Birth Asphyxia
Interventions: Drug: Normal saline placebo;   Drug: erythropoietin
19 Completed Safety Study of Erythropoietin (EPO) in Parkinson's Disease
Condition: Parkinson Disease
Intervention: Drug: Erythropoietin human recombinant (EPOrh)
20 Completed Erythropoietin Therapy for Children With Cerebral Palsy: Phase 1
Condition: Cerebral Palsy
Intervention: Drug: Erythropoietin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.